HALO - Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
Story updates
08:33:34 PM UTC
SquawkNews
Halozyme proposes a $1.05 billion offering of convertible senior notes due 2033, plus a $150 million option to initial purchasers.Key Highlights:Original SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - 8-K - Sep. 16, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verify…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.